Copyright
©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 95987
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95987
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95987
Minimal risk | Low to intermediate risk | High risk | Unacceptable risk |
Current | |||
NMIBC – in situ and T1 | Prostate cancer-Gleason score 7 | Prostate cancer- Gleason score >7 | Metastatic prostate cancer |
Prostate cancer - Gleason score ≤ 6 | RCC 1-4 cm and Fuhrman grade I/II | RCC > 7 cm and Fuhrman grade III/IV | RCC stages T3/T4 |
RCC < 1 cm and Fuhrman grade I/II | RCC 4-7 cm and Fuhrman grade I/II | MIBC – post chemoradiation | |
History | |||
Prostate cancer Gleason up to 6 Prostate cancer Gleason = 7 after curative treatment and cancer-free period > 5 yr | RCC 1-4 cm, FG I/II; RCC 4-7 cm, FG I/II | Prostate cancer with extraprostatic spread | Any metastatic genitourinary malignancy |
RCC < 1 cm and FG I/II | RCC > 7 cm and FG III/IV | RCC stages T3/T4 |
Cancer | Tumor stage and/or grade | Time interval to transplant |
Prostate | Up to T3 stage and regardless of Gleason score | No wait time |
Metastatic castration-sensitive prostatic cancer | Stable disease for 2 yr with prolonged estimated life expectancy – 2 yr | |
Metastatic castration-resistant | Not a LT candidate | |
Renal cell carcinoma | T1a (≤ 4 cm) and T1b (4-7 cm) with N0, M0 and Fuhrman grade I/II | No wait time |
T1b, N0, M0 and FG III/IV and T2N0M0 | 2 yr | |
T3 and T4 – both N0M0 | Minimum 2 yr then reassess | |
Any T, N+, M+ | Not a LT candidate | |
Bladder | NMIBC (solitary tumor, low grade, absence of carcinoma in situ (CIS), high grade tumor < 3 cm) | 6 mo |
NMIBC (any CIS, high-grade tumor > 3 cm, high grade T1 tumor, any recurrent high-grade Ta tumor, lymphovascular invasion) | 2 yr | |
MIBC, postradical cystectomy | 2 yr | |
MIBC, post chemoradiation | Not a LT candidate |
- Citation: Sesa V, Silovski H, Basic-Jukic N, Kosuta I, Sremac M, Mrzljak A. Genitourinary tumors and liver transplantation: A comprehensive review. World J Transplant 2024; 14(3): 95987
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/95987.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.95987